Quick answer
Constipation is listed among the most common adverse reactions in the FDA-approved labeling for both semaglutide injection and semaglutide tablets, reviewed here as of September 2026. The labeling's own clinical pharmacology states that semaglutide delays gastric emptying, and NIDDK separately lists slow movement of stool through your colon among the causes of constipation in anyone. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) sets the bar for what counts as constipation at all, and the section below states it in full. Fluids and everyday dietary fiber are the general ground to stand on, and a short list of symptoms, including an inability to pass gas together with vomiting, means contacting a clinician the same day.
*The short version*
- The labeling for semaglutide injection and for semaglutide tablets each list constipation among the most common adverse reactions.
- The mechanism is on the label, not inferred: semaglutide delays gastric emptying.
- The Medication Guide instructs patients to drink fluids to help reduce the chance of dehydration, and to report nausea, vomiting, or diarrhea that does not go away.
- Fiber without enough fluid can make constipation worse instead of better.
- Never change, hold, or skip a prescribed dose on your own. That is the prescribing physician's decision.
- This page does not name an over the counter product, and a section below explains why.
What constipation actually means
People use the word to mean different things, so it is worth pinning down. NIDDK describes constipation as a condition in which you may have fewer than three bowel movements a week, stools that are hard, dry, or lumpy, stools that are difficult or painful to pass, or a feeling that not all stool has passed. It adds a caveat that gets lost in most advice: people can have different bowel movement patterns, and only you know what is normal for you.
NIDDK also frames it in a way worth carrying into any clinical conversation: "Constipation is not a disease, but may be a symptom of another medical problem. Constipation may last for a short or long time." That is why a new pattern on a new medicine is worth mentioning rather than absorbing quietly.
What the semaglutide labeling says about constipation
The FDA-approved labeling settles whether this is a recognized effect, and it does.
The labeling for semaglutide injection lists constipation among the most common adverse reactions, alongside nausea, diarrhea, vomiting, and abdominal pain. The tablet labeling lists it there too, alongside nausea, abdominal pain, diarrhea, decreased appetite, and vomiting. Both forms of the molecule carry it, so you are not imagining the connection.
One thing worth keeping straight: the two labelings carry different approved indications, so what a medicine is approved for is worth asking rather than assuming.
We do not restate the full adverse reaction list here. It lives in our semaglutide side effects guide.
Why does semaglutide cause constipation?
Most pages tell you the medicine "slows digestion." The labeling is more specific, and more useful.
The injection labeling's clinical pharmacology section states plainly, under its own heading: "Gastric Emptying Semaglutide delays gastric emptying." The tablet labeling describes the same effect, noting that the mechanism of blood glucose lowering "also involves a minor delay in gastric emptying in the early postprandial phase," and, in its pharmacodynamics section, that semaglutide "causes a delay of early postprandial gastric emptying, thereby reducing the rate at which glucose appears in the circulation postprandially."
That is what the labeling states, and what it states is about the stomach. NIDDK separately lists slow movement of stool through your colon among the general causes of constipation in anyone, and lists hard, dry, or lumpy stools among the symptoms. No source read for this page states how far the label's gastric effect reaches down the digestive tract, so we are not going to fill that gap with a guess.
NIDDK lists three other causes that tend to arrive together when appetite drops: not eating enough fiber, not drinking enough liquids or dehydration, and not getting enough physical activity. If you are eating less overall, you are very likely eating less fiber, and fluid intake often quietly follows food volume down. That is not a personal failure. It is the arithmetic of a smaller appetite.
One more item from the same NIDDK list deserves attention: certain medicines and dietary supplements can make constipation worse. Semaglutide is not the only thing you take, so bring the whole list to your physician, supplements included.
How long does semaglutide constipation last?
Here is where most articles quietly make something up.
The labeling instructs clinicians to monitor renal function in patients reporting adverse reactions that could lead to volume depletion, and it names the beginning of treatment and changes in treatment as the period needing the closest attention. That is the label's own framing of when gastrointestinal effects deserve the closest attention: around the start of treatment and around changes in it.
What the labeling does not give is an average duration, so we do not quote one, and you should be skeptical of any page that does. It varies from person to person, it is often uncomfortable rather than dangerous, and persistent symptoms are a reason to contact your physician rather than to keep waiting.
Fluids, dehydration, and your kidneys
This is the part of the page with the most weight behind it, and the part most likely to be skimmed.
The Medication Guide for semaglutide is direct: "Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away."
The prescribing information carries the clinical version of the same concern. Under acute kidney injury due to volume depletion, it notes postmarketing reports of acute kidney injury in patients treated with semaglutide, and states that "The majority of the reported events occurred in patients who experienced gastrointestinal adverse reactions leading to dehydration such as nausea, vomiting, or diarrhea." Its information for patients section tells clinicians to "Advise patients to take precautions to avoid fluid depletion."
So fluids are not a folk remedy here. They are a label instruction.
We will not give you an ounce target, because there is no single target and NIDDK does not give one either. What NIDDK says is: "Ask a health care professional how much liquid you should drink each day based on your size, health, activity level, and where you live." If you have kidney or heart conditions, that question is not a formality. Ask it.
Does more fiber help, and how much fluid goes with it?
NIDDK's nutrition guidance for constipation opens with two sentences that belong together and are usually separated: eat enough fiber, and drink plenty of liquids to help the fiber work better.
On quantity, NIDDK cites general government dietary guidance: depending on your age and sex, adults should get 22 to 34 grams of fiber a day. That is what the government publishes for adults generally, not a figure calibrated to you and not a treatment dose. NIDDK's own next line matters more: "Talk with a health care professional, such as a dietitian, to plan meals with the right amount of fiber for you. Be sure to add fiber to your diet a little at a time so your body gets used to the change."
The food categories NIDDK lists are ordinary: whole grains, legumes, fruits, vegetables, and nuts.
MedlinePlus adds the pairing rule in the bluntest available form: "When you increase fiber in your diet, you also need to get enough fluids. Not getting enough fluids may make constipation worse instead of better. Ask your health care provider or dietitian how much fluid you should be getting each day." More fiber on top of low fluid intake is the single most common way people make this worse while trying to make it better.
Eating well on a reduced appetite is its own subject, and we treat it as one in what to eat on semaglutide.
Movement and routine
Two self-care measures from NIDDK cost nothing and are usually skipped.
The first is regular physical activity. NIDDK lists it among the ways to relieve symptoms, and lists not getting enough of it among the causes of constipation. That is the whole claim, without embellishment.
The second is bowel training, which almost no article covers. NIDDK suggests trying to have a bowel movement at the same time each day to become more regular, and is specific about timing: "For example, trying to have a bowel movement 15 to 45 minutes after breakfast may help, because eating helps your colon move stool." It adds three things that sound trivial and are not: give yourself enough time, use the bathroom as soon as you feel the need to go, and relax your muscles, including putting your feet on a footstool. NIDDK lists ignoring the urge to have a bowel movement among the routine changes that can change your bowel movements, and its treatment page says to use the bathroom as soon as you feel the need to go.
Can you prevent semaglutide constipation before it starts?
Nothing prevents it reliably, and any page that says otherwise is selling something. What exists is ground worth standing on before the first dose rather than after the first bad week.
The measures are the ones above, started earlier: the fluid intake your clinician says fits your size, health and activity level; everyday dietary fiber added a little at a time rather than all at once; regular physical activity; and a consistent bathroom routine, including not putting off the urge. NIDDK lists not eating enough fiber, not drinking enough liquids, and not getting enough physical activity among the causes of constipation generally, which is why they are also the things to keep steady when appetite drops.
The part most people skip is the least glamorous: tell the physician who prescribed it early rather than late, and bring the full list of what else you take, supplements included. A clinician who hears about a change in week one has options that a clinician who hears about it in week six does not.
What the labeling means by severe gastrointestinal reactions
"Severe" is not a figure of speech here. It is a category the labeling recognizes, with its own section.
The labeling states that use has been associated with gastrointestinal adverse reactions, sometimes severe, and that "Severe gastrointestinal adverse reactions have also been reported postmarketing with GLP-1 receptor agonists."
The labeling's postmarketing section, which collects reports received after approval rather than trial results, lists among gastrointestinal disorders reported with semaglutide: ileus, intestinal obstruction, and severe constipation including fecal impaction. Read that with the caution the labeling itself attaches to it: "Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure." It is a list of what has been reported, not a statement of how often it happens or of what caused it. It is also the reason the red flags in the next section are worth knowing before you need them.
The same section states that the medicine is not recommended in patients with severe gastroparesis, which is a condition of delayed stomach emptying in its own right. The information for patients section instructs clinicians to "Instruct patients to contact their healthcare provider if they have severe or persistent gastrointestinal symptoms."
Read that as written: the labeling anticipates that some gastrointestinal reactions will be severe and tells patients to contact a clinician when they are. An unusually bad episode is a phone call, not a test of endurance.
When should you call a clinician the same day?
NIDDK publishes a specific list of symptoms that mean seeing a doctor right away when you have constipation:
- bleeding from your rectum
- blood in your stool
- constant pain in your abdomen
- inability to pass gas
- vomiting
- fever
- lower back pain
- losing weight without trying
NIDDK also says to see a doctor if symptoms do not go away with self-care, or if you have a family history of colon or rectal cancer. The Medication Guide adds a line for anyone on semaglutide: tell your healthcare provider if you have stomach problems that are severe or will not go away.
One combination deserves separating from the rest. An inability to pass gas, together with vomiting and a swollen, tender abdomen, is an in person evaluation today: an emergency department or urgent care question, not a message and wait question. Nothing you read anywhere replaces being examined when that is the picture.
Ordinary discomfort that is not improving is exactly what a message to your care team is for. You can start at our help center.
What a physician actually looks at
Here is what a visit for this actually involves.
NIDDK describes the evaluation this way: "Doctors use your medical and family history, a physical exam, or medical tests to diagnose and find the cause of your constipation." In practice that history covers prior digestive tract surgery, recent weight change, and any history of anemia; how often you have a bowel movement, how long symptoms have lasted, what your stools look like and whether there is blood; and your eating habits, physical activity, and every medicine and supplement you take, since several drug categories make constipation worse.
The physical exam is not a formality either. NIDDK describes checking blood pressure, temperature, and heart rate, checking for dehydration, listening to sounds in your abdomen, and checking the abdomen for swelling, tenderness or pain, and masses. Depending on what that turns up, lab, imaging, or endoscopic tests may follow.
One thing you can do beforehand costs nothing: NIDDK suggests tracking your bowel movements and what your stools look like for several days first. A written record beats a recollection.
And one thing only a prescribing clinician can do is the reason this symptom belongs in a clinical conversation rather than a comment thread. How treatment is paced, whether it is held, and what happens next are clinical decisions made with your whole record in view. NIDDK states the general rule: do not change or stop any medicine or supplement without talking with a health care professional. Report the symptom and let the decision be made by someone equipped to make it.
Why does this page not name a product to take?
You came here, quite reasonably, wanting to be told what to take. We are not going to, and you deserve the reason rather than a silence.
The right over the counter choice depends on your kidney function, the other medicines and supplements you already take, your history, and how long this has been going on. A web page knows none of that about you, and any page that names a product anyway is guessing on your behalf while sounding certain. Some of these categories bear on kidney function specifically, the same organ the labeling already flags in the context of dehydration. That is a bad place to guess.
NIDDK puts the decision in the same hands we do: "Your health care professional may recommend using a laxative for a short time. He or she will tell you what type of laxative is best for you."
So the answer to the question you searched is a person, not a product. Message your physician, say how long it has been going on, list everything you take including supplements, and let the recommendation come from someone who can see your record. Our help center is the place to start if you are not sure who to ask.
Tablets, injections, and other GLP-1 medications
Both semaglutide forms reviewed here describe a delay in gastric emptying and both list constipation among the most common adverse reactions, so this page applies whether the semaglutide you take is injected or taken by mouth.
The broader picture across the medication class is a separate subject. If tirzepatide is the medicine in question, we cover it in tirzepatide and constipation. For the full range of effects rather than this one, see our semaglutide side effects guide.
If you take compounded semaglutide
This question comes up constantly, so here is the straight version. Compounded medications are not FDA-approved as final products. There is therefore no FDA-approved labeling for a compounded preparation, and the labeling quoted throughout this page is the labeling of approved semaglutide products. Any question about a specific compounded preparation belongs with the licensed physician who prescribed it and with the pharmacy that prepared it, and it is a fair question to ask directly.
This article is for informational purposes only and does not constitute medical advice. Medication is prescribed only if a licensed physician determines it is appropriate.
Frequently Asked Questions
How do you keep from getting constipated on semaglutide?
Nothing prevents it reliably, but the general ground is the same ground NIDDK describes for constipation in anyone: enough fluid, everyday dietary fiber added gradually rather than all at once, regular physical activity, and a consistent bathroom routine. The Medication Guide for semaglutide separately instructs patients to drink fluids to help reduce the chance of dehydration. The other half of prevention is telling your physician early instead of late, because a clinician has options a self-care list does not.
How long does constipation from semaglutide last?
It varies from person to person, and we are not going to quote an average, because the labeling does not give one. What the labeling does say is that clinicians should monitor renal function in patients reporting adverse reactions that could lead to volume depletion, and it points to the beginning of treatment and to changes in treatment as the period needing the closest attention. It does not say how often symptoms appear then, and neither will we. If it is not improving with the general measures above, that is a reason to message your physician rather than a reason to keep waiting.
Can semaglutide cause a bowel obstruction?
Yes, in the sense that matters for a search result: the labeling's postmarketing section lists ileus, intestinal obstruction, and severe constipation including fecal impaction among reported gastrointestinal disorders, while stating that such voluntary reports cannot establish how often they happen or that the drug caused them. That is a reason to know the warning signs, not a reason to expect them. The signs are specific: severe abdominal pain, repeated vomiting, a swollen or tender abdomen, or an inability to pass gas. That combination is an in person evaluation today, at an emergency department or urgent care, not a message and wait.
What is the best laxative for semaglutide constipation?
This page will not name one, and the reason is not squeamishness. The right choice depends on your kidney function, the other medicines and supplements you take, your history, and how long this has been going on, and a web page cannot know any of that about you. NIDDK puts the same decision with a clinician: a health care professional may recommend an over the counter option for a short time and will tell you what type is best for you. Message your physician, or start at [our help center](/help).
Is there a seven second trick that relieves constipation immediately?
No. None of the primary sources reviewed for this article describe an instant method, and we are not going to invent one. What does exist is unglamorous and well documented: fluids, everyday dietary fiber introduced gradually, regular physical activity, a consistent bathroom routine, and a clinician for anything beyond that.
Should I lower or skip my dose because of constipation?
Never on your own. Tell the physician who prescribed it. How treatment is paced, whether it is held, and what happens next are clinical decisions, and they are made with the rest of your record in view. NIDDK gives the general version of the same rule: do not change or stop any medicine or supplement without talking with a health care professional.
Does constipation mean the medication is working?
No. Constipation is a recognized gastrointestinal adverse reaction listed in the labeling, not a progress signal, and nothing in the labeling ties it to any outcome. Treating a side effect as evidence of progress is a good way to tolerate something you should be reporting instead.
Does this happen with tirzepatide too?
This page reviewed the semaglutide labeling only, so it will not characterize another medicine's labeling. What the semaglutide labeling itself says is that severe gastrointestinal adverse reactions have also been reported postmarketing with GLP-1 receptor agonists. If tirzepatide is the medicine in question, we cover it separately in [tirzepatide and constipation](/blog/tirzepatide-constipation).
Is compounded semaglutide different in this respect?
The active ingredient is semaglutide either way, and the gastrointestinal effects described on this page come from the FDA-approved labeling for approved semaglutide products. Compounded medications are not FDA-approved as final products, so there is no FDA-approved labeling for a compounded preparation to quote. Any question about a specific compounded preparation belongs with the licensed physician who prescribed it and the pharmacy that prepared it, and it is a fair question to ask both directly.
Sources
This article is based on the following primary sources. Links open the original documents.
- 1.Semaglutide injection prescribing information, section 5.5 Acute Kidney Injury Due to Volume Depletion · DailyMed, U.S. National Library of Medicine · accessed
- 2.Semaglutide injection prescribing information, section 5.6 Severe Gastrointestinal Adverse Reactions · DailyMed, U.S. National Library of Medicine · accessed
- 3.Semaglutide injection prescribing information, section 6.2 Postmarketing Experience · DailyMed, U.S. National Library of Medicine · accessed
- 4.Semaglutide injection prescribing information, section 12.2 Pharmacodynamics · DailyMed, U.S. National Library of Medicine · accessed
- 5.Semaglutide injection prescribing information, section 17 Information for Patients · DailyMed, U.S. National Library of Medicine · accessed
- 6.Semaglutide injection Medication Guide, dehydration leading to kidney problems · DailyMed, U.S. National Library of Medicine · accessed
- 7.Semaglutide tablet prescribing information, section 12.1 Mechanism of Action · DailyMed, U.S. National Library of Medicine · accessed
- 8.Semaglutide tablet prescribing information, section 12.2 Pharmacodynamics, Gastric emptying · DailyMed, U.S. National Library of Medicine · accessed
- 9.Definition and Facts for Constipation · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 10.Definition and Facts for Constipation, definition of constipation · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 11.Symptoms and Causes of Constipation · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 12.Eating, Diet, and Nutrition for Constipation, fiber · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 13.Eating, Diet, and Nutrition for Constipation, daily fiber · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 14.Eating, Diet, and Nutrition for Constipation, liquids · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 15.Diagnosis of Constipation · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 16.Treatment for Constipation, who chooses an over the counter option · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 17.Treatment for Constipation, bowel training · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 18.High-fiber foods, patient instructions · MedlinePlus, U.S. National Library of Medicine · accessed
Is this available in your state?
Telehealth rules differ by state, and so does what a physician can prescribe remotely. Each state page covers the local telehealth requirements, whether a video visit is required, and the current status of our physician coverage there.
- California
- Texas
- Florida
- New York
- Pennsylvania
- Illinois
- Ohio
- Georgia
- North Carolina
- Michigan
- Arizona
- Washington
Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.
- Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
- Documented compliance review against FDA, FTC and LegitScript requirements before publication
- External sources, where an article cites them, are listed at the end of that article with links to the original documents
- Compounded medications are described as not FDA-approved as final products on every page that mentions them
